Paper Details

  1. Home
  2. Paper Details

Omalizumab for asthma in adults and children.

Author: MilanStephen J, NairParameswaran, NormansellRebecca, WalkerSamantha, WaltersE Haydn

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This article discusses the use of omalizumab, an anti-IgE drug, for the treatment of inadequately controlled severe persistent allergic IgE-mediated asthma. Omalizumab is recommended as add-on therapy in adults and children over six years of age who require continuous or frequent treatment with oral corticosteroids.
Paper Details　
Original Abstract of the Article :
Asthma is a respiratory (airway) condition that affects an estimated 300 million people worldwide and is associated with significant morbidity and mortality. Omalizumab is a monoclonal antibody that binds and inhibits free serum immunoglobulin E (IgE). It is called an 'anti-IgE' drug. IgE is an immu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD003559.pub4

データ提供：米国国立医学図書館（NLM）

Omalizumab: A New Weapon in the Fight Against Asthma

Asthma, a chronic respiratory condition, affects millions around the world. It's like a persistent sandstorm, making it difficult to breathe. This study explores the potential of omalizumab, a monoclonal antibody, as a treatment for asthma. The study reviews the current evidence and guidelines, providing a comprehensive overview of omalizumab's role in managing asthma.

Omalizumab: Targeting IgE to Combat Asthma

Omalizumab, like a skilled desert nomad navigating treacherous dunes, targets IgE, a key mediator of allergic reactions. The study highlights the growing body of evidence supporting omalizumab's use as an add-on therapy in patients with severe persistent allergic asthma. The study points to the potential of omalizumab to improve asthma control and reduce the need for corticosteroids, offering a significant benefit to patients with this debilitating condition.

What's the Impact for Asthma Sufferers?

This study sheds light on a promising new treatment option for asthma. It's important to note that omalizumab is not a cure for asthma, but it can be a valuable tool in managing the condition. If you are struggling with asthma, talk to your doctor about the potential of omalizumab as a treatment option.

Dr.Camel's Conclusion

This study, like a rare desert flower blooming in the harshest conditions, offers hope for asthma sufferers. It highlights the power of targeted therapies in combating complex diseases. The study encourages further research into the use of omalizumab and other innovative approaches to managing asthma.

Date :
  1. Date Completed 2014-07-01
  2. Date Revised 2022-03-16
Further Info :

Pubmed ID

24414989

DOI: Digital Object Identifier

10.1002/14651858.CD003559.pub4

Related Literature

Article Analysis
・Effects of beclomethasone oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.